 | Citius Pharmaceuticals, Inc. | |||
| NCM : CTXR || Location: United States | ||||
$0.71-0.06 (-7.43%) |
0.77 M | 0.7 - 0.77 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 12.425 M |
| March 15, 2024 | 12.180 M |
| Feb. 29, 2024 | 11.863 M |
| Feb. 15, 2024 | 11.581 M |
| Jan. 31, 2024 | 11.614 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | 0.13 | -0.06 | -145.25% |
| 09/30/2023 | -0.02 | -0.08 | -292.16% |
| 06/30/2023 | -0.06 | -0.06 | -6.95% |
| 03/31/2023 | -0.04 | -0.07 | -96.08% |
| 09/30/2022 | -0.04 | -0.05 | -22.55% |
CTXR Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 159.095M | Shares Float | 146.773M |
| Short Float | 12.425M | Market Cap | 122.50M |
| Institution ownership | 17.10% | Insider ownership | 7.736% |
| Earnings Date | 05/10/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.26 | Forward EPS | 0.12 |